Stockreport

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2% [Yahoo! Finance]

XOMA Corporation  (XOMA) 
Last xoma corporation earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.xoma.com/investor-relations
PDF XOMA further expands its late-stage portfolio with synthetic royalty and milestone interests in two additional women's health assets: Ovaprene ® , an investigational po [Read more]